Dr. Charles Landis, MD
Claim this profileUniversity of Washington (UW) - Harborview Medical Center (HMC) - Hepatitis and Liver Clinic
Studies Non-alcoholic Fatty Liver Disease
Studies Fatty Liver Disease
5 reported clinical trials
6 drugs studied
Area of expertise
1Non-alcoholic Fatty Liver Disease
Stage I
Stage II
2Fatty Liver Disease
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Charles Landis, MD is currently running
HM15211
for Non-alcoholic Steatohepatitis (NASH)
This trial is testing a medication called HM15211 to see if it can help people with a liver disease called NASH. The study will check if the medication is safe and effective over a period of time.
Recruiting0 awards Phase 23 criteria
Volixibat
for Itching in Primary Sclerosing Cholangitis
The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.
Recruiting0 awards Phase 26 criteria
More about Charles Landis, MD
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Charles Landis, MD has experience with
- Tirzepatide
- HM15211
- Placebo Of HM15211
- Albutein 20% Injectable Solution
- Volixibat
- Placebo
Breakdown of trials Charles Landis, MD has run
Non-alcoholic Fatty Liver Disease
Fatty Liver Disease
Fibrosis
Cirrhosis
Ascites
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Charles Landis, MD specialize in?
Charles Landis, MD focuses on Non-alcoholic Fatty Liver Disease and Fatty Liver Disease. In particular, much of their work with Non-alcoholic Fatty Liver Disease has involved Stage I patients, or patients who are Stage II.
Is Charles Landis, MD currently recruiting for clinical trials?
Yes, Charles Landis, MD is currently recruiting for 2 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Charles Landis, MD has studied deeply?
Yes, Charles Landis, MD has studied treatments such as Tirzepatide, HM15211, Placebo of HM15211.
What is the best way to schedule an appointment with Charles Landis, MD?
Apply for one of the trials that Charles Landis, MD is conducting.
What is the office address of Charles Landis, MD?
The office of Charles Landis, MD is located at: University of Washington (UW) - Harborview Medical Center (HMC) - Hepatitis and Liver Clinic, Seattle, Washington 98104 United States. This is the address for their practice at the University of Washington (UW) - Harborview Medical Center (HMC) - Hepatitis and Liver Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.